kelly, I don't think so. Those bio companies just prefer paying royalties to HDVY rather than buying its shares. This way, they have less risks.
Actually, I think we shouldn't be surprised for the volumes in that HDVY has nearly 190 million S/O although it's good for the increases lately. It's been hanging around $0.20's ranges for a while.